Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK' and Ligand = 'BDBM281744'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM281744 ((RS)-5-(2-Acryloyl-1,2,3,4-tetrahydroisoquinolin-5...) Show SMILES NC(=O)c1cc(F)c(-c2cccc3CN(CCc23)C(=O)C=C)c2c3CC(F)(F)CCc3[nH]c12 |(.48,5.78,;-.86,5,;-2.19,5.77,;-.86,3.46,;.48,2.69,;.48,1.15,;1.81,.38,;-.86,.38,;-.86,-1.16,;-2.19,-1.93,;-2.19,-3.47,;-.86,-4.24,;.48,-3.47,;1.81,-4.24,;3.14,-3.47,;3.14,-1.93,;1.81,-1.16,;.48,-1.93,;4.48,-4.24,;4.48,-5.78,;5.81,-3.47,;7.15,-4.24,;-2.19,1.15,;-3.65,.68,;-4.28,-.73,;-5.81,-.89,;-5.81,-2.43,;-7.15,-1.66,;-6.72,.36,;-6.09,1.76,;-4.56,1.92,;-3.65,3.17,;-2.19,2.69,)| Show InChI InChI=1S/C25H22F3N3O2/c1-2-20(32)31-9-7-14-13(12-31)4-3-5-15(14)21-18(26)10-16(24(29)33)23-22(21)17-11-25(27,28)8-6-19(17)30-23/h2-5,10,30H,1,6-9,11-12H2,(H2,29,33)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.120	n/a	n/a	n/a	n/a	7.4	25
Bristol-Myers Squibb Company US Patent					Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...				US Patent US10023534 (2018) BindingDB Entry DOI: 10.7270/Q2WW7KQR
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM281744 ((RS)-5-(2-Acryloyl-1,2,3,4-tetrahydroisoquinolin-5...) Show SMILES NC(=O)c1cc(F)c(-c2cccc3CN(CCc23)C(=O)C=C)c2c3CC(F)(F)CCc3[nH]c12 |(.48,5.78,;-.86,5,;-2.19,5.77,;-.86,3.46,;.48,2.69,;.48,1.15,;1.81,.38,;-.86,.38,;-.86,-1.16,;-2.19,-1.93,;-2.19,-3.47,;-.86,-4.24,;.48,-3.47,;1.81,-4.24,;3.14,-3.47,;3.14,-1.93,;1.81,-1.16,;.48,-1.93,;4.48,-4.24,;4.48,-5.78,;5.81,-3.47,;7.15,-4.24,;-2.19,1.15,;-3.65,.68,;-4.28,-.73,;-5.81,-.89,;-5.81,-2.43,;-7.15,-1.66,;-6.72,.36,;-6.09,1.76,;-4.56,1.92,;-3.65,3.17,;-2.19,2.69,)| Show InChI InChI=1S/C25H22F3N3O2/c1-2-20(32)31-9-7-14-13(12-31)4-3-5-15(14)21-18(26)10-16(24(29)33)23-22(21)17-11-25(27,28)8-6-19(17)30-23/h2-5,10,30H,1,6-9,11-12H2,(H2,29,33)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.180	n/a	n/a	n/a	n/a	7.4	25
Bristol-Myers Squibb Company US Patent					Assay Description To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...				US Patent US10023534 (2018) BindingDB Entry DOI: 10.7270/Q2WW7KQR
					More data for this Ligand-Target Pair